Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.02 +0.03 (+2.82%)
At close: Oct 21, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Current Debt (2013)

Updated

Tvardi Therapeutics' Current Debt came in at $1.46 million for Q1 2013.

Analysis

Tvardi Therapeutics (TVRD) Current Debt (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Tvardi Therapeutics 9.57 Mn -98.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 1.46 Mn
API Access

Tvardi Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TVRD&period=max&api_key=YOUR_API_KEY